Migraine in Postural Orthostatic Tachycardia Syndrome (POTS) (P3.126)
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: Headache characteristics were prospectively studied in 41 consecutive patients with postural orthostatic tachycardia syndrome (POTS).
Background: POTS, the most prevalent form of orthostatic intolerance, is a heterogeneous disorder that is associated with a number of symptoms, including headache. The prevalence and clinical features of headache and how it relates to clinical signs and symptoms in POTS patients have not been widely reported.
Design/Methods: Forty-one consecutive new patients undergoing an evaluation for POTS were included in this study. All patients underwent a clinical interview including evaluation of headache, completed a composite autonomic symptom score (COMPASS) questionnaire, illness intrusiveness scale questionnaire, autonomic testing, and routine laboratory studies.
Results: A total of 41 patients were included in the study; 36 were female, mean age 25, with a mean autonomic symptom duration of 4.6 years. All but 2 patients reported a history of headache, 73% of patients reported a headache onset prior to age 20, and 12% reported headache onset in conjunction with autonomic symptoms. Chronic migraine (CM) was diagnosed in 25 (61%), episodic migraine (EM) in 12 (29%), new persistent daily headache in 1 patient, and orthostatic headache in 1 patient. When compared with EM, those with CM had higher COMPASS scores, higher scores on illness intrusiveness scale, lower supine norepinephrine values, and were more likely to have abnormal blood pressure profile with the Valsalva maneuver on autonomic testing.
Conclusions: Headache is present in nearly all patients with POTS. CM was present in nearly 2/3’s of the patients in this cohort and was associated with more severe autonomic symptoms, greater perception of symptom disability, lower supine norepinephrine levels, and greater likelihood of blood pressure abnormality with the Valsalva maneuver, relative to patients with EM.
Disclosure: Dr. VanderPluym has nothing to disclose. Dr. Hoffman-Snyder has nothing to disclose. Dr. Khoury has nothing to disclose. Dr. Goodman has nothing to disclose.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
- No related articles found.